1. Burke, R. E., and K. O'Malley. 2013. 'Axon degeneration in Parkinson's disease', Exp Neurol, 246: 72-83.
2. Adalbert, R., and M. P. Coleman. 2013. 'Review: Axon pathology in age-related neurodegenerative disorders', Neuropathol Appl Neurobiol, 39: 90-108.
3. Jenner, P. 2008. 'Molecular mechanisms of L-DOPA-induced dyskinesia', Nat Rev Neurosci, 9: 665-77.
4. Wu, H. Y., E. Hudry, T. Hashimoto, K. Kuchibhotla, A. Rozkalne, Z. Fan, T. SpiresJones, H. Xie, M. Arbel-Ornath, C. L. Grosskreutz, B. J. Bacskai, and B. T. Hyman. 2010. 'Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation', J Neurosci, 30: 2636-49
5. Boros, B. D., K. M. Greathouse, E. G. Gentry, K. A. Curtis, E. L. Birchall, M. Gearing, and J. H. Herskowitz. 2017. 'Dendritic spines provide cognitive resilience against Alzheimer's disease', Ann Neurol, 82: 602-14.
6. Suarez, L. M., O. Solis, J. M. Carames, I. R. Taravini, J. M. Solis, M. G. Murer, and R. Moratalla. 2014. 'L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice', Biol Psychiatry, 75: 711-22.
7. Villalba, R. M., and Y. Smith. 2018. 'Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?', J Neural Transm (Vienna), 125: 431-47.
8. Bajjalieh, S. M., G. D. Frantz, J. M. Weimann, S. K. McConnell, and R. H. Scheller. 1994. 'Differential expression of synaptic vesicle protein 2 (SV2) isoforms', J Neurosci, 14: 5223-35.
9. Bajjalieh, S. M., K. Peterson, M. Linial, and R. H. Scheller. 1993. 'Brain contains two forms of synaptic vesicle protein 2', Proc Natl Acad Sci U S A, 90: 2150-4.
10. Finnema, S. J., N. B. Nabulsi, T. Eid, K. Detyniecki, S. F. Lin, M. K. Chen, R. Dhaher, D. Matuskey, E. Baum, D. Holden, D. D. Spencer, J. Mercier, J. Hannestad, Y. Huang, and R. E. Carson. 2016. 'Imaging synaptic density in the living human brain', Sci Transl Med, 8: 348ra96.
11. Finnema, S.J., N.B. Nabulsi, J. Mercier, S.F. Lin, M.K. Chen, D. Matuskey, J.D. Gallezot, S. Henry, J. Hannestad, Y. Huang, and R.E. Carson. 2017. 'Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans', J Cereb Blood Flow Metab: 271678X17724947-.
12. Stockburger, C., D. Miano, M. Baeumlisberger, T. Pallas, T. N. Arrey, M. Karas, K. Friedland, and W. E. Muller. 2016. 'A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam', J Alzheimers Dis, 50: 201-15.
13. Li, S., Z. Cai, X. Wu, D. Holden, R. Pracitto, M. Kapinos, H. Gao, D. Labaree, N. Nabulsi, R. E. Carson, and Y. Huang. 2019. 'Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates', ACS Chem Neurosci, 10: 1544-54.
14. Cai, H., T. J. Mangner, O. Muzik, M. W. Wang, D. C. Chugani, and H. T. Chugani. 2014. 'Radiosynthesis of (11)C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression', ACS Med Chem Lett, 5: 1152-5.